Edesa Biotech, Inc. — Cash Flow Charts
34 quarters of history · ending 2021-09-30 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-281.2% -$2M
$-3M
Free Cash Flow
$-4K
Investing Cash Flow↓-58.7% -$2K
$1K
Financing Cash Flow↓-93.2% -$3M
$221K
Capex
$4K
Stock-Based Comp↑+947.2% +$818K
$905K
Debt Repaid
—
D&A↓-0.3% -$85
$29K
SBC Allocated Expense↑+947.2% +$818K
$905K
SBC Unrecognized Cost
$1M
SBC Granted (Grant-Date FV)NEW
—